Interventional pulmonology use of cell-free DNA assay for metastatic non–small cell lung cancer: the UC Davis experience

BACKGROUND: Interventional pulmonologists (IPs) are often the first specialist to see patients with suspected metastatic non–small cell lung cancer (mNSCLC). Consequently, they are potentially ideally positioned to expedite the identification of actionable molecular mutations by ordering blood-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Phan, Chinh, Jespersen, Forrest, Weipert, Caroline, Li, Tianhong, Yoneda, Ken Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647290/
https://www.ncbi.nlm.nih.gov/pubmed/36346075
http://dx.doi.org/10.1177/17534666221135324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647290/
https://www.ncbi.nlm.nih.gov/pubmed/36346075
http://dx.doi.org/10.1177/17534666221135324

Ejemplares similares